Dorota Šebelová

Lékařská Fakulta Univerzita Palackého v Olomouci
Country flagCzech Republic

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (5)

Year:

2025

Year:

2024

Year:

2024

Neurodegenerative diseases are a broad heterogeneous group affecting the nervous system. They are characterized, from a pathophysiological perspective, by the selective involvement of a subpopulation of nerve cells with a consequent clinical picture of a disease. Clinical diagnoses of neurodegenerative diseases are quite challenging and often not completely accurate because of their marked heterogeneity and frequently overlapping clinical pictures. Efforts are being made to define sufficiently specific and sensitive markers for individual neurodegenerative diseases or groups of diseases in order to increase the accuracy and speed of clinical diagnosis. Thus said, this present research aimed to identify biomarkers in the cerebrospinal fluid (CSF) and serum (α‐synuclein [α‐syn], tau protein [t‐tau], phosphorylated tau protein [p‐tau], β‐amyloid [Aβ], clusterin, chromogranin A [chromogrA], cystatin C [cyst C], neurofilament heavy chains [NFH], phosphorylated form of neurofilament heavy chains [pNF‐H], and ratio of tau protein/amyloid beta [Ind tau/Aβ]) that could help in the differential diagnosis and differentiation of the defined groups of α‐synucleinopathies and four‐repeat (4R‐) tauopathies characterized by tau protein isoforms with four microtubule‐binding domains. In this study, we analyzed a cohort of 229 patients divided into four groups: (1) Parkinson's disease (PD) + dementia with Lewy bodies (DLB) ( n = 82), (2) multiple system atrophy (MSA) ( n = 25), (3) progressive supranuclear palsy (PSP) + corticobasal syndrome (CBS) ( n = 30), and (4) healthy controls (HC) ( n = 92). We also focused on analyzing the biomarkers in relation to each other with the intention of determining whether they are useful in distinguishing among individual proteinopathies. Our results indicate that the proposed set of biomarkers, when evaluated in CSF, is likely to be useful for the differential diagnosis of MSA versus 4RT. However, these biomarkers do not seem to provide any useful diagnostic information when assessed in blood serum. image

Year:

2023

Year:

2022

Collaborators (6)

Radoslav Matej

Professor and Chair

Fakultní Nemocnice Hradec Králové

CZECH REPUBLIC
View details

Petr Kaňovský

-

CZECH REPUBLIC
View details

David Friedecký

-

CZECH REPUBLIC
View details

Michal Kaleta

University Hospital Olomouc

CZECH REPUBLIC
View details

Ondřej Novák

-

CZECH REPUBLIC
View details

Kateřina Menšíková

University Hospital Olomouc

CZECH REPUBLIC
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.